Stephen Rubino
Director/Board Member at VIRACTA THERAPEUTICS, INC.
Net worth: - $ as of 2024-04-29
Network origin in Stephen Rubino first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.
117
| Subsidiary | Pharmaceuticals: Major | 117 |
| Public Company | Biotechnology | 25 | |
| Public Company | Biotechnology | 10 | |
Sporos Bioventures, Inc.
 Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino.
8
| Holding Company | Medical/Nursing Services | 8 |
Sermonix Pharmaceuticals LLC
 Sermonix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Sermonix Pharmaceuticals LLC operates as a pharmaceutical company that focuses on the development and commercialization of late-stage women?s health products. It offers lasofoxifene, a selective estrogen receptor modulator for the treatment of vulvovaginal atrophy, as well as treatment and prevention of post-menopausal osteoporosis. The company was founded in 2014 by David Portman and is headquartered in Columbus, OH.
7
| Holding Company | Pharmaceuticals: Major | 7 |
| Public Company | Biotechnology | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Stephen Rubino via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Chief Operating Officer Human Resources Officer Public Communications Contact General Counsel Corporate Officer/Principal Compliance Officer | |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member Chairman Director of Finance/CFO Director/Board Member Director/Board Member | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal General Counsel President Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Executive Officer General Counsel Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO President President Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Graduate Degree Undergraduate Degree | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Investor Private Equity Investor | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal General Counsel General Counsel | ||
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Asylia Therapeutics, Inc.
 Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| SERES THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| University of California San Diego | College/University | Corporate Officer/Principal Undergraduate Degree Masters Business Admin | |
| The Johns Hopkins University | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | President President Corporate Officer/Principal | |
| HealthCare Institute of New Jersey | Director/Board Member Director/Board Member Director/Board Member | ||
| RUBIUS THERAPEUTICS | Biotechnology | Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
| The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| AXCA HEALPAR | Biotechnology | Chairman Chief Executive Officer | |
| MANNKIND CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Yale University | College/University | Corporate Officer/Principal Doctorate Degree | |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Medical Specialties | President Corporate Officer/Principal | |
| EXACT SCIENCES CORPORATION | Medical Specialties | Director/Board Member Sales & Marketing | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Novartis Pharma KK
 Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Novartis Pharma KK develops, imports, produces and sells pharmaceutical products. The company was founded on April 1, 1997 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Ethicon Corp.
 Ethicon Corp. Medical SpecialtiesHealth Technology Ethicon Corp. manufactures and markets surgical sutures. The company is headquartered in Somerville, NJ. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| University of Cambridge | College/University | Graduate Degree Graduate Degree | |
| PULMATRIX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of Wisconsin | College/University | Masters Business Admin Undergraduate Degree | |
Sprout Pharmaceuticals, Inc.
 Sprout Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sprout Pharmaceuticals, Inc. provides delivery of a treatment option for the unmet need of women with Hypoactive Sexual Desire Disorder. The company was founded by Cynthia E. Whitehead and Robert S. Whitehead on November 29, 2011 and is headquartered in Raleigh, NC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| SANOFI | Miscellaneous Commercial Services | General Counsel Chief Executive Officer | |
Tvardi Therapeutics, Inc.
 Tvardi Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tvardi Therapeutics, Inc. develops and commercializes medicines for the treatment of diverse cancers, chronic inflammatory and fibrotic diseases. The company was founded by David J. Tweardy and Ronald A. DePinho in 2017 and is headquartered in Houston, TX. | Miscellaneous Commercial Services | Director/Board Member Consultant / Advisor | |
| University of San Diego | College/University | Undergraduate Degree Undergraduate Degree |
Statistics
International
| United States | 46 |
| United Kingdom | 3 |
| Switzerland | 2 |
| Japan | 2 |
| France | 2 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 12 |
| Commercial Services | 4 |
| Finance | 2 |
| Technology Services | 2 |
Operational
| Director/Board Member | 397 |
| Corporate Officer/Principal | 263 |
| Independent Dir/Board Member | 119 |
| Chairman | 75 |
| President | 74 |
Most connected contacts
| Insiders | |
|---|---|
| Michael Wyzga | 31 |
| Ivor Royston | 30 |
| Roger Pomerantz | 30 |
| Michael Friedman | 30 |
| Michael Perry | 28 |
| David Epstein | 28 |
| Mark Iwicki | 26 |
| Thomas Paul Koestler | 26 |
| Isaac Cheng | 25 |
| Richard de Schutter | 24 |
| Alex Gorsky | 23 |
| Alexandre LeBeaut | 22 |
| Tony H. Wild | 22 |
| Gary Phillips | 20 |
| Jean-Jacques Garaud | 17 |
- Stock Market
- Insiders
- Stephen Rubino
- Company connections
